scispace - formally typeset
R

R. Suzanne Zukin

Researcher at Albert Einstein College of Medicine

Publications -  31
Citations -  4811

R. Suzanne Zukin is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Long-term potentiation & NMDA receptor. The author has an hindex of 25, co-authored 31 publications receiving 4271 citations. Previous affiliations of R. Suzanne Zukin include Yeshiva University.

Papers
More filters
Journal ArticleDOI

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

TL;DR: An emerging concept is that activity-dependent, bidirectional regulation of NMDAR trafficking provides a dynamic and potentially powerful mechanism for the regulation of synaptic efficacy and remodelling, which, if dysregulated, can contribute to neuropsychiatric disorders such as cocaine addiction, Alzheimer's disease and schizophrenia.
Journal ArticleDOI

Dysregulation of mTOR Signaling in Fragile X Syndrome

TL;DR: Elevated mTOR signaling may provide a functional link between overactivation of group I mGluRs and aberrant synaptic plasticity in the fragile X mouse, mechanisms relevant to impaired cognition in fragile X syndrome.
Journal ArticleDOI

Protein kinase C modulates NMDA receptor trafficking and gating.

TL;DR: It is demonstrated that PKC increases NMDA channel opening rate and delivers new NMDA channels to the plasma membrane through regulated exocytosis and regulates NMDAR channel gating and trafficking in recombinant systems and in neurons, mechanisms that may be relevant to synaptic plasticity.
Journal ArticleDOI

Protein kinase A regulates calcium permeability of NMDA receptors

TL;DR: This work shows that the Ca2+ permeability of neuronal NMDARs is under the control of the cyclic AMP–protein kinase A (cAMP-PKA) signaling cascade and provides a new mechanism whereby PKA regulates the induction of LTP.
Journal ArticleDOI

The emerging field of epigenetics in neurodegeneration and neuroprotection

TL;DR: Although not somatically heritable, epigenetic modifications in neurons are dynamic and reversible, which makes them good targets for therapeutic intervention, especially in neurodegenerative disorders and diseases.